Modeling Metformin and Dapagliflozin Pharmacokinetics in Chronic Kidney Disease

Shahidehpour, A., Rashid, M., Askari, M. R., Ahmadasas, M., Abdel-Latif, M., Fritschi, C., Quinn, L., Reutrakul, S., Bronas, U. G., & Cinar, A. (2024). Modeling Metformin and Dapagliflozin Pharmacokinetics in Chronic Kidney Disease. The AAPS Journal, 26(5). https://doi.org/10.1208/s12248-024-00962-2
Authors:
Andrew Shahidehpour
Mudassir Rashid
Mohammad Reza Askari
Mohammad Ahmadasas
Mahmoud Abdel-Latif
Cynthia Fritschi
Lauretta Quinn
Sirimon Reutrakul
Ulf G Bronas
Ali Cinar
Affiliated Authors:
Ulf G Bronas
Columbia Affiliation:
Subjects:
Benzhydryl Compounds (MeSH)
Metformin (MeSH)
Glucosides (MeSH)
Renal Insufficiency, Chronic (MeSH)
Glomerular Filtration Rate (MeSH)
Models, Biological (MeSH)
Hypoglycemic Agents (MeSH)
Author Keywords:
chronic kidney disease
dapagliflozin
metformin
modeling
pharmacokinetics
elink
Publication Type:
Article
Unique ID:
10.1208/s12248-024-00962-2
PMID:
39160349
DOI:
10.1208/s12248-024-00962-2
Journal:
AAPS Journal
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: